1. Home
  2. ELEV vs MHUA Comparison

ELEV vs MHUA Comparison

Compare ELEV & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • MHUA
  • Stock Information
  • Founded
  • ELEV 2019
  • MHUA 1990
  • Country
  • ELEV United States
  • MHUA China
  • Employees
  • ELEV N/A
  • MHUA N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • ELEV Health Care
  • MHUA Health Care
  • Exchange
  • ELEV Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • ELEV 22.8M
  • MHUA 19.6M
  • IPO Year
  • ELEV 2021
  • MHUA 2022
  • Fundamental
  • Price
  • ELEV $0.38
  • MHUA $0.44
  • Analyst Decision
  • ELEV Hold
  • MHUA
  • Analyst Count
  • ELEV 6
  • MHUA 0
  • Target Price
  • ELEV $1.77
  • MHUA N/A
  • AVG Volume (30 Days)
  • ELEV 2.0M
  • MHUA 197.0K
  • Earning Date
  • ELEV 08-05-2025
  • MHUA 04-25-2025
  • Dividend Yield
  • ELEV N/A
  • MHUA N/A
  • EPS Growth
  • ELEV N/A
  • MHUA N/A
  • EPS
  • ELEV N/A
  • MHUA 0.40
  • Revenue
  • ELEV N/A
  • MHUA $96,909,642.00
  • Revenue This Year
  • ELEV N/A
  • MHUA N/A
  • Revenue Next Year
  • ELEV N/A
  • MHUA N/A
  • P/E Ratio
  • ELEV N/A
  • MHUA $1.11
  • Revenue Growth
  • ELEV N/A
  • MHUA N/A
  • 52 Week Low
  • ELEV $0.22
  • MHUA $0.25
  • 52 Week High
  • ELEV $3.28
  • MHUA $1.47
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 62.35
  • MHUA 55.31
  • Support Level
  • ELEV $0.38
  • MHUA $0.41
  • Resistance Level
  • ELEV $0.39
  • MHUA $0.45
  • Average True Range (ATR)
  • ELEV 0.01
  • MHUA 0.05
  • MACD
  • ELEV 0.00
  • MHUA -0.00
  • Stochastic Oscillator
  • ELEV 85.00
  • MHUA 51.07

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: